(Q40568575)

English

Treatment of HER-2/neu overexpressing breast cancer xenograft models with trastuzumab (Herceptin) and gefitinib (ZD1839): drug combination effects on tumor growth, HER-2/neu and epidermal growth factor receptor expression, and viable hypoxic cell fr

scientific article published on April 2004

Statements

Treatment of HER-2/neu overexpressing breast cancer xenograft models with trastuzumab (Herceptin) and gefitinib (ZD1839): drug combination effects on tumor growth, HER-2/neu and epidermal growth factor receptor expression, and viable hypoxic cell fr (English)
Corinna Warburton
Wieslawa H Dragowska
Karen Gelmon
Stephen Chia
Hong Yan
Dana Masin
Tetyana Denyssevych
Anne E Wallis
Marcel B Bally
1 April 2004
2512-2524

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit